CD36 and atherosclerosis: Since CD36 is a key player in metabolic diseases, like NASH, atherosclerosis 65, diabetes 66, and it can be influenced by both lipid levels and palmitoylation, CD36 palmitoylation is likely to be a crucial mechanism underlying lipid-induced metabolic disorders.